Special items: Ovarian Cancer and Us blog best viewed in Firefox

▼
Showing posts with label biomarker. Show all posts
Showing posts with label biomarker. Show all posts
Friday, January 20, 2012

abstract: Pre-Treatment Tumor Expression of ERCC1 in Women with Advanced Stage Epithelial Ovarian Cancer is Not Predictive of Clinical Outcomes: A GOG study

›
Conclusions ERCC1 expression, measured by IHC in pre-treatment tumor specimens, using a highly specific antibody, has limited clinical ...
Thursday, December 29, 2011

Treatment-related protein biomarker expression differs between primary and recurrent ovarian carcinomas

›
Saturday, May 28, 2011

Editorial - no abstract/pay-per-view: - Gynecologic Oncology : More than a biomarker: CA125 may contribute to ovarian cancer pathogenesis

›
Abstract Gynecologic Oncology Volume 121, Issue 3 , 1 June 2011, Pages 429-430 Editorial More than a biom...
Sunday, November 14, 2010

Interleukin (IL)-18, a biomarker of human ovarian carcinoma, is predominantly released as biologically inactive precursor (negative study)

›
Friday, August 20, 2010

In research - Georgia Tech Team Claims 100 Percent Accuracy for Metabolomic Ovarian Cancer Test in Initial Trial ProteoMonitor GenomeWeb

›
........"In ovarian cancer, the single protein that's commonly used [as a biomarker], CA-125, is not a very accurate test ," ...
Tuesday, August 17, 2010

Arresting Development: Blood Biomarker Patterns May Aid Early Diagnosis of Ovarian Cancer: Scientific American

›
Note : in research
Saturday, August 14, 2010

Expert Opinion on Medical Diagnostics - KRAS mutations - Summary

›
What the reader will gain: KRAS mutations in mCRC and NSCLC primary tumors predict resistance to EGFR-targeted therapy. In pancreatic cance...
Wednesday, July 21, 2010

A KRAS-Variant in Ovarian Cancer Acts as a Genetic Marker of Cancer Risk (full access)

›
Friday, July 02, 2010

full free access: - Women's Health - Ovarian cancer biomarker screening: still too early to tell

›
"In 2004, the US Preventive Services Task Force (amongst other countries/guidelines ) recommended against routine ovarian cancer screen...
Monday, June 28, 2010

abstract: Clinical Biochemistry : Nidogen-2: A new serum biomarker for ovarian cancer (multinational study)

›
Conclusions: Nidogen-2 is a new biomarker for ovarian cancer which correlates closely with CA125.
Tuesday, June 15, 2010

p53 autoantibodies as potential detection and prognostic biomarkers in serous ovarian cancer

›
IMPACT: Although their utility as a preoperative diagnostic biomarker, beyond CA 125 and HE4, is limited, p53-AAb are prognostic for impr...

A KRAS-variant as a biomarker of ovarian cancer risk

›
Note: KRAS has been studied in colorectal cancer impacting on treatment program/no indication if ovarian cancer/Lynch Syndrome patients were...
Monday, April 26, 2010

Ontario Institute for Cancer Research Announces Three New Equity Investments -- TORONTO, April 26 /PRNewswire/ --

›
Note: press release has further information on the investments: 1)Novel Cellular Immunotherapy for Cancer; 2)Next Generation Biomarker A...
Tuesday, April 06, 2010

Editorial: A Step Forward for Two-Step Screening for Ovarian Cancer - Journal of Clinical Oncology

›
A Step Forward for Two-Step Screening for Ovarian Cancer   Martee L. Hensley, Department of Medicine, Gynecologic Medical Oncology Service...
Monday, April 05, 2010

HE4: a new potential early biomarker for the recurrent ovarian cancer

›
"The follow-up study showed an increase of HE4 5-8 months before CA125 increment in five of the eight patients, this early expressio...